Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 15 (PPIAP15)

Target
PPIAP15
Molecular classification
Pseudogene, Long non-coding RNA (lncRNA) candidate
01

Overview

Peptidylprolyl isomerase A pseudogene 15 (PPIAP15) is a non-coding pseudogene that shares sequence homology with the functional gene Peptidylprolyl isomerase A (PPIA), also known as cyclophilin A[4][5]. PPIAP15 does not encode a functional protein and is considered a genomic remnant or "fossil" according to human gene nomenclature guidelines[5]. Its biological function is uncharacterized, and there is no evidence suggesting direct roles in disease or as a drug target. Although some PPIA pseudogenes such as PPIAP22 have been shown to function as long non-coding RNAs and participate in gene regulation in cancer, there is no supporting evidence for PPIAP15’s involvement in such regulatory networks or any disease association in the current literature[2][3][4][5].\n\nSummary: \nPPIAP15 is a pseudogene, not a therapeutic target; it is primarily relevant as a non-coding genomic sequence and does not encode an active protein or participate directly in molecular pathways currently associated with drug action or disease phenotypes[4][5]. Any reference to its role as a direct therapeutic target is inaccurate.

Other names
PPIP5
02

Mechanism of action

None (No direct pharmacological mechanisms, as no protein product exists)

03

Biological functions

Likely lacks classical protein function (a pseudogene by definition is unable to produce a functional protein)Possible roles at RNA level as lncRNA or ceRNA, inferred from similar PPIA pseudogenes (e.g., PPIAP22)
04

Disease associations

No direct evidence for PPIAP15 disease role in provided literatureBy analogy, some PPIA pseudogenes (e.g., PPIAP22) have regulatory/network effects in cancer through competing endogenous RNA activity, but no experimental or clinical links for PPIAP15 identified

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 15 (PPIAP15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 15 (PPIAP15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call